Arcutis Biotherapeutics, Inc. ARQT Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

CarGurus, Inc.CARG

-$613K-186%

SeaboardSEB

$0-100%

HTF

Heartflow, Inc. Common StockHTFL

26,200,000%+17,776,022pp

RepligenRGEN

-$145K-104%

FTI ConsultingFCN

-$4.67M-179%

Other financials

Income statement

See full

Revenue$105.4M+60.1%

Gross profit$95.6M+67.7%

Operating income-$9.1M+62.9%

Net income-$11.3M+54.9%

EPS (diluted)-$0.09+55.0%

Balance sheet

See full

Cash & equivalents$35.1M-34.7%

Total debt$114.7M+3.5%

Total equity$189.6M+32.9%

Total assets$460.0M+33.7%

Cash flow

See full

Operating cash flow$2.2M+107%

CapEx--100%

Free cash flow$2.2M+107%

Valuation

See full

Market cap$3.29B+57.5%

Profitability

See full

Gross margin90.9%+2.5pp

Operating margin-12%-5.7pp

Net margin-13.9%-6.6pp

FCF margin-52.5%-21.9pp

Returns & leverage

See full

Return on equity-28.2%-13.0pp

Debt / equity0.6×-0.2×

Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: Arcutis Biotherapeutics, Inc. (ARQT) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$119K in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: Arcutis Biotherapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 3075.0% year-over-year, from $4K to -$119K.